100 related articles for article (PubMed ID: 15620705)
1. Short and highly efficient synthetic promoters for melanoma-specific gene expression.
Martinelli R; De Simone V
FEBS Lett; 2005 Jan; 579(1):153-6. PubMed ID: 15620705
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
[TBL] [Abstract][Full Text] [Related]
3. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
[TBL] [Abstract][Full Text] [Related]
4. MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Schoensiegel F; Paschen A; Sieger S; Eskerski H; Mier W; Rothfels H; Kleinschmidt J; Schadendorf D; Haberkorn U
Cancer Gene Ther; 2004 Jun; 11(6):408-18. PubMed ID: 15118759
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells.
Siders WM; Halloran PJ; Fenton RG
Cancer Res; 1996 Dec; 56(24):5638-46. PubMed ID: 8971169
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
Emiliusen L; Gough M; Bateman A; Ahmed A; Voellmy R; Chester J; Diaz RM; Harrington K; Vile R
Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
[TBL] [Abstract][Full Text] [Related]
7. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
8. Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer.
Chen EQ; Song XQ; Wang YL; Zhou TY; Bai L; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2011 Mar; 65(2):125-31. PubMed ID: 21108965
[TBL] [Abstract][Full Text] [Related]
9. Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses.
Hurtado Picó A; Wang X; Sipo I; Siemetzki U; Eberle J; Poller W; Fechner H
Mol Ther; 2005 Apr; 11(4):563-77. PubMed ID: 15771959
[TBL] [Abstract][Full Text] [Related]
10. Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
Tomizawa M; Saisho H; Tagawa M
Anticancer Res; 2003; 23(4):3273-7. PubMed ID: 12926063
[TBL] [Abstract][Full Text] [Related]
11. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma.
Rothfels H; Paschen A; Schadendorf D
Exp Dermatol; 2003 Dec; 12(6):799-810. PubMed ID: 14714561
[TBL] [Abstract][Full Text] [Related]
13. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
[TBL] [Abstract][Full Text] [Related]
14. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma.
Park BJ; Brown CK; Hu Y; Alexander HR; Horti J; Raje S; Figg WD; Bartlett DL
Hum Gene Ther; 1999 Apr; 10(6):889-98. PubMed ID: 10223723
[TBL] [Abstract][Full Text] [Related]
17. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions].
Zeng H; Liao YC; Wang F; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):782-5. PubMed ID: 16334552
[TBL] [Abstract][Full Text] [Related]
18. Efficient lipofection with cisplatin-resistant human tumor cells.
Huang L; Son K; Gao X; Hages D; Yang YY; Holden SA; Teicher B; Kirkwood J; Lazo JS
Cancer Gene Ther; 1996; 3(2):107-12. PubMed ID: 8729909
[TBL] [Abstract][Full Text] [Related]
19. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of human alpha-fetoprotein gene by C/EBPalpha].
Lee K
Hokkaido Igaku Zasshi; 2004 Jul; 79(4):377-87. PubMed ID: 15373210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
